Month: July 2025
PayPal beats on earnings, raises full-year outlook as Venmo growth accelerates
PayPal reported better-than-expected results for the second quarter and raised its full-year guidance for transaction margin dollars and earnings per share. The stock slipped more than 4% following the report. Here’s how the company did compared with Wall Street estimates, based on a survey of analysts by LSEG: Earnings per share: $1.40 adjusted vs. $1.30 expected […]
Read More
Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance
Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were […]
Read More
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook
Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches […]
Read More
Boeing reports results before the bell. Here’s what to expect
The nose cone of a Boeing 787 being displayed on the tarmac during the Paris Air Show at Le Bourget Airport, outside Paris, June 25, 2023. Nicolas Economou | Nurphoto | Getty Images Boeing is expected to report a smaller second-quarter loss when it reports its earnings Tuesday morning. Investors will also hear from CEO […]
Read More
UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers
UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023. Patrick T. Fallon | Afp | Getty Images UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s insurance unit continues to grapple with higher medical costs. The company anticipates it will […]
Read More
Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal
Shelf of pharmaceutical products. D3sign | Moment | Getty Images Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive sector-specific levies could risk blowing up the entire deal. Ambiguity abounds around the terms for pharmaceutical goods under the trade truce agreed Sunday, which imposes […]
Read More
With Trump pressure and a ‘new Lebanon,’ can Hezbollah’s shadow economy be dismantled?
Key Points “Hezbollah finds itself in its greatest predicament since its foundation,” one regional expert told CNBC. Hezbollah makes money from industries like banking and construction, but also runs international drug trafficking and smuggling operations as far afield as Bulgaria and Argentina. Its revenues are estimated in the billions of dollars annually. Following Israel’s aggressive […]
Read More
The EU-U.S. trade deal could have one unexpected winner: The UK
Keir Starmer, UK prime minister, left, and US President Donald Trump, ahead of their meeting at the Trump Turnberry golf course in Turnberry, Scotland, on Monday, July 28, 2025. Tolga Akmen/EPA/Bloomberg via Getty Images As world leaders and economists across Europe digest the news of the EU-U.S. trade agreement, some experts told CNBC that while […]
Read More
Samsung backs South Korean AI chip startup Rebellions ahead of IPO
The Rebel-Quad is the second-generation product from Rebellions and is made up of four Rebel AI chips. Rebellions, a South Korean firm, is looking to rival companies like Nvidia in AI chips. Rebellions South Korean artificial intelligence chip startup Rebellions has raised money from tech giant Samsung and is targeting a funding round of up […]
Read More
Philips shares soar 11% as health tech giant flags reduced U.S. tariff impact
Philips jumps on improved tariff outlook Shares of Philips soared nearly 14% at the market open, after the Dutch consumer healthcare group raised its full-year margin outlook, saying it now expects a hit of 150 to 200 million euros ($230.1 million) from tariffs, down from the 250 to 300 million euros it had previously estimated. […]
Read More